Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Avash Kalra

Concepts (48)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Liver Transplantation
3
2018
706
1.100
Why?
End Stage Liver Disease
2
2018
63
1.080
Why?
Waiting Lists
2
2018
211
0.630
Why?
Hepatitis, Autoimmune
1
2018
27
0.610
Why?
Resource Allocation
1
2018
37
0.600
Why?
Lymphocytes
1
2017
333
0.490
Why?
Liver Cirrhosis
1
2017
228
0.490
Why?
Graft Rejection
1
2018
516
0.490
Why?
Tissue and Organ Procurement
1
2018
228
0.490
Why?
Liver Neoplasms
1
2018
509
0.460
Why?
Glucocorticoids
1
2018
534
0.460
Why?
Neutrophils
1
2017
1164
0.380
Why?
Adenocarcinoma, Mucinous
1
2023
61
0.200
Why?
Organ Transplantation
1
2023
159
0.180
Why?
Carcinoma, Pancreatic Ductal
1
2023
212
0.180
Why?
Withholding Treatment
1
2018
68
0.150
Why?
Lymphocyte Count
1
2017
133
0.140
Why?
Pancreatic Neoplasms
1
2023
733
0.130
Why?
Tissue Donors
1
2018
317
0.130
Why?
Gastrointestinal Agents
1
2014
60
0.110
Why?
Multivariate Analysis
1
2017
1440
0.110
Why?
Colitis
1
2014
226
0.100
Why?
Autoimmune Diseases
1
2014
392
0.090
Why?
Case-Control Studies
1
2017
3008
0.090
Why?
Severity of Illness Index
1
2017
2542
0.080
Why?
Prognosis
1
2017
3344
0.080
Why?
Time Factors
1
2018
6125
0.080
Why?
Antibodies, Monoclonal
1
2014
1270
0.070
Why?
Biomarkers
1
2017
3418
0.070
Why?
Treatment Outcome
1
2018
9105
0.060
Why?
Humans
5
2023
114937
0.060
Why?
Risk Factors
1
2017
8637
0.060
Why?
Antineoplastic Agents
1
2014
1897
0.050
Why?
United States
1
2018
12211
0.050
Why?
Pancreas
1
2023
277
0.040
Why?
Middle Aged
1
2017
26806
0.030
Why?
Prevalence
1
2023
2252
0.030
Why?
Ipilimumab
1
2014
29
0.030
Why?
Male
2
2017
55663
0.030
Why?
Infliximab
1
2014
94
0.030
Why?
Diarrhea
1
2014
173
0.030
Why?
Hypotension
1
2014
113
0.030
Why?
Female
1
2017
59581
0.020
Why?
Critical Illness
1
2014
643
0.020
Why?
Melanoma
1
2014
631
0.020
Why?
Acute Kidney Injury
1
2014
638
0.020
Why?
Retrospective Studies
1
2023
12544
0.020
Why?
Aged
1
2014
19122
0.010
Why?
Kalra's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)